Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Pilot Study to Assess the Usability and Feasibility of OPTDR01 as an Automated Diabetic Retinopathy Screening Tool

NCT06343350 is registered in ClinicalTrials.gov with Optain Health as lead sponsor.

NCT NCT06343350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06343350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Pilot Study to Assess the Usability and Feasibility of OPTDR01 as an Automated Diabetic Retinopathy Screening Tool
Lead sponsor
Optain Health
Phase
Observational
Overall status
Completed
Start date
April 1, 2024
Completion date
October 30, 2025
Enrollment
300 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetic retinopathy